•
Jun 30, 2023

Avidity Biosciences Q2 2023 Earnings Report

Total Revenue
$2.32M
Previous year: $2.18M
+6.3%
EPS
-$0.66
Previous year: -$0.92
-28.3%
Gross Profit
$1.06M
Previous year: -$37.6M
-102.8%
Cash and Equivalents
$154M
Previous year: $125M
+23.0%
Free Cash Flow
-$50.4M
Previous year: -$36.9M
+36.8%
Total Assets
$611M
Previous year: $421M
+45.1%

Avidity Biosciences

Avidity Biosciences